Evolus vs Harrow
Evolus and Harrow are similar in size: $297m and $272m of revenue in their latest fiscal years. Harrow grew faster (36.4% against 11.6%). Harrow kept more of each dollar of sales as profit: a net margin of -1.9% against -17.4%.
| Latest fiscal year | EvolusEOLS, 2025 | HarrowHROW, 2025 |
|---|---|---|
| Revenue | $297m | $272m |
| Revenue growth | 11.6% | 36.4% |
| Net income | −$51.6m | −$5.1m |
| Operating margin | -11.0% | — |
| Net margin | -17.4% | -1.9% |
| Return on equity | — | -8.4% |
| Free cash flow | −$45.7m | $43.0m |
| Cash | $53.8m | $72.9m |
| Total debt | $150m | $250m |
| Debt to equity | — | — |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | — | — |
| Employees | 334 | — |
| Market value | $481m | $1.06bn |
| Price vs our value range | — | Above our value range |
| Moat score | 10 (Weak) | 26 (Weak) |
| Insider trades, 12 months | 0 buys, 7 sales | 4 buys, 7 sales |